Back to Search Start Over

Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma

Authors :
Firas Baidoun
Zahi Merjaneh
Fatma Abd-Elshahed Abd-Elhay
Mohamed Gomaa Kamel
Source :
Translational Oncology, Vol 14, Iss 9, Pp 101156- (2021)
Publication Year :
2021
Publisher :
Elsevier, 2021.

Details

Language :
English
ISSN :
19365233
Volume :
14
Issue :
9
Database :
Directory of Open Access Journals
Journal :
Translational Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.77c73c23848e43e3b6be5ae7f9074912
Document Type :
article
Full Text :
https://doi.org/10.1016/j.tranon.2021.101156